Platform Technology Partners Precision Biosciences Inc Transaction History

Platform Technology Partners

  • $312 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 12, 2023
BUY
$0.52 - $0.91 $520 - $910
1,000 Added 3.85%
27,000 $14,000
Q4 2022

Jan 11, 2023
BUY
$0.97 - $45.0 $970 - $45,000
1,000 Added 4.0%
26,000 $0
Q3 2022

Oct 24, 2022
BUY
$1.22 - $40.8 $30,500 - $1.02 Million
25,000 New
25,000 $33,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $584M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Platform Technology Partners Portfolio

Follow Platform Technology Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

News

Stay updated on Platform Technology Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email